You live inside my mind

Attendees at EPA 2015

Into our mid-morning sessions, and the symposium on The Role of Neuroinflammation and Infection in Bipolar Disorder and Schizophrenia, with a particular focus on exploring some of the factors influencing bipolar disorder.

The toxic avenger

 

The first session by Professor A. Sutherland looked at the role of Toxoplasma gondii, a parasite that infects 30 to 80 percent of the world’s population, and how it impacts bipolar disorder.

In infected mice, the parasite has been shown to manipulate behaviour, making them more active and willing to take risks, with a slower reaction time, ability to learn and pay attention, and a reduced fear of cats.

This adaptation of behaviour makes sense as cats are the parasite’s primary host, so increasing risky behaviours in mice increases the chance that a cat will eat them, but how do parasite-induced brain changes affect humans?

 

Gondii in sixty seconds

 

Humans infected with T. gondii have slower reaction times and cognitive performance, and increased risks of suicidal behaviour and dying in traffic accidents (which may be due to the decreased reaction times).

To work out the association with bipolar disorder, Prof Sutherland performed a meta-analysis and showed a significant association (OR 1.52, p=0.02) between T. gondii and bipolar disorder

 

Many systems, one condition

 

The role of infection in bipolar disorder was further examined by Professor M. Leboyer.

Prof Leboyer opened her presentation by proposing a move away from the traditional perspective of bipolar disorder. Instead of considering bipolar as a cyclical illness characterised by full-blown manic or depressive episodes interspersed with normal euthymic periods, Prof Leboyer proposed a more holistic perspective of a subtle, chronic, progressive, multi-system disorder.

 

We all respond differently

 

Bipolar is also associated with a lot of other conditions – obesity, diabetes, hypertension, auto-immune disorders – so Prof Leboyer proposed that this may be due to a broader multi-system inflammatory disorder.

In particular, Prof Leboyer focused on immunogenetic variety; the way that genes can influence response to pathogens. She presented data that showed that immune dysregulation due to variations in Toll-Like Receptor genes, among others, may be more common in early-onset bipolar disorder patients.

 

The hits keep coming

 

Prof Leboyer combined these aspects of her presentation together by presenting a ‘multiple hit’ model of vulnerability to bipolar disorder, where ‘hits’ throughout childhood – prenatal infection, childhood trauma – can all combine to induce an ongoing chronic mild inflammation, which is a risk factor for the subsequent development bipolar disorder.

 

Pass it on

 

Two fascinating talks rounded out another great morning for this correspondent. Though now Toxoplasma gondii gets added just below Ebola on my ‘Microorganisms to be terrified of’ list.

Continue the conversation on Twitter at #EPA2015Vienna

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country